Olaratumab Plus Doxorubicin in Advanced Soft Tissue Sarcoma
2 意见
• 07/18/23
0
0
嵌入
William D. Tap, MD, chief, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses results from a phase Ib/II presented at the 2015 Connective Tissue Oncology Society (CTOS) Annual Meeting.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论